Evolus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Evolus and other ETFs, options, and stocks.

About EOLS

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. 

CEO
David Moatazedi
CEODavid Moatazedi
Employees
334
Employees334
Headquarters
Newport Beach, California
HeadquartersNewport Beach, California
Founded
2012
Founded2012
Employees
334
Employees334

EOLS Key Statistics

Market cap
416.20M
Market cap416.20M
Price-Earnings ratio
-9.43
Price-Earnings ratio-9.43
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$6.32
High today$6.32
Low today
$6.20
Low today$6.20
Open price
$6.32
Open price$6.32
Volume
5.31K
Volume5.31K
52 Week high
$10.62
52 Week high$10.62
52 Week low
$3.86
52 Week low$3.86

Stock Snapshot

The current Evolus(EOLS) stock price is $6.32, with a market capitalization of 416.2M. The stock trades at a price-to-earnings (P/E) ratio of -9.43.

As of 2026-05-12, Evolus(EOLS) stock has fluctuated between $6.20 and $6.32. The current price stands at $6.32, placing the stock +1.9% above today's low and 0.0% off the high.

Evolus(EOLS) shares are trading with a volume of 5.31K, against a daily average of 1.23M.

During the past year, Evolus(EOLS) stock moved between $3.86 at its lowest and $10.62 at its peak.

During the past year, Evolus(EOLS) stock moved between $3.86 at its lowest and $10.62 at its peak.

EOLS News

TipRanks 22h
Evolus announces commercial launch of Estyme in Europe

Evolus (EOLS) announced that the commercial launch of Estyme, its injectable hyaluronic acid gel collection in Europe, is scheduled for May 16th, marking the co...

TipRanks 6d
Evolus Faces Heightened Operational Risk from Overseas Manufacturing and Disaster Recovery Gaps

Evolus, Inc. (EOLS) has disclosed a new risk, in the Supply Chain category. Unlock hedge fund-level data and powerful investing tools for smarter, sharper deci...

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own EOLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.